| Literature DB >> 34901449 |
Sónia Barros1, Joana Roseira1, Paulo Caldeira1, Ana Margarida Vaz1, Horácio Guerreiro1, Oscar Codon2.
Abstract
Prostate cancer is the second most frequent cancer in men worldwide. Dose escalation is currently the standard of care for the treatment of prostate cancer with radiation therapy. However, the rectum tends to be the dose-limiting structure when treating prostate cancer, given its proximity. The injection of biodegradable spacers between the prostate and the rectum may optimize radiotherapy treatment delivery for patients with localized disease. Nevertheless, although the overall complication rate of spacers is marginal, the benefits of spacer technologies need to be evaluated against the complication risks such as rectum perforation/necrosis. We report a case of a 59-year-old man with a diagnosis of prostate adenocarcinoma for whom hormonal treatment followed by intensity modulated radiation therapy (IMRT) was proposed. A biodegradable and expandable balloon (BioProtect®) was injected into the perirectal space without detectable immediate complications. One month later, the patient presented with a 3-day persistent rectal bleeding. The investigation confirmed a rectal perforation by the balloon spacer system.Entities:
Keywords: Adverse effects; Endoscopy; Intensity-modulated radiotherapy; Rectal perforation; Rectal spacer
Year: 2020 PMID: 34901449 PMCID: PMC8630386 DOI: 10.1159/000511647
Source DB: PubMed Journal: GE Port J Gastroenterol ISSN: 2387-1954